Literature DB >> 26331117

Evading the fate of Pheidippides: acute coronary thrombosis in a young marathon runner with minimal atherosclerosis but sickle cell trait.

Scott W Murray1, Robert M Cooper1, Joseph D Mills1, Nicholas D Palmer1.   

Abstract

Marathon running transiently increases the risk of sudden cardiac death. Some previous studies have suggested that this is due to relatively advanced but asymptomatic atherosclerosis. Other theories suggest that potentiation of inflammation and the coagulation cascade, by extremes of exertion, is more important. We present a clinical case of a young, previously fit athlete who felt chest discomfort eight miles into a marathon but finished the race. Shortly after completion he felt very unwell and had chest pain. Ambulance electrocardiograms showed evidence of an evolving anterior myocardial infarction. Invasive assessment with coronary angiography and intravascular ultrasound was able to show the mechanism of thrombosis. Fissuring of a small rim of atherosclerosis potentiated a large pro-thrombotic response, the patient was also found to have sickle cell trait. Medical treatment with blood thinning drugs was able to restore normality to the vessel over a period of two weeks, without the need for angioplasty or stent implantation.

Entities:  

Keywords:  Marathon running; coronary thrombosis; intravascular ultrasound; plaque vulnerability

Year:  2015        PMID: 26331117      PMCID: PMC4536480          DOI: 10.3978/j.issn.2223-3652.2015.05.03

Source DB:  PubMed          Journal:  Cardiovasc Diagn Ther        ISSN: 2223-3652


  8 in total

1.  Exercise and physical activity in the prevention and treatment of atherosclerotic cardiovascular disease: a statement from the Council on Clinical Cardiology (Subcommittee on Exercise, Rehabilitation, and Prevention) and the Council on Nutrition, Physical Activity, and Metabolism (Subcommittee on Physical Activity).

Authors:  Paul D Thompson; David Buchner; Ileana L Pina; Gary J Balady; Mark A Williams; Bess H Marcus; Kathy Berra; Steven N Blair; Fernando Costa; Barry Franklin; Gerald F Fletcher; Neil F Gordon; Russell R Pate; Beatriz L Rodriguez; Antronette K Yancey; Nanette K Wenger
Journal:  Circulation       Date:  2003-06-24       Impact factor: 29.690

Review 2.  Potential adverse cardiovascular effects from excessive endurance exercise.

Authors:  James H O'Keefe; Harshal R Patil; Carl J Lavie; Anthony Magalski; Robert A Vogel; Peter A McCullough
Journal:  Mayo Clin Proc       Date:  2012-06       Impact factor: 7.616

3.  Intravascular ultrasound and virtual histology interpretation of plaque rupture and thrombus in acute coronary syndromes.

Authors:  S W Murray; N D Palmer
Journal:  Heart       Date:  2009-09       Impact factor: 5.994

Review 4.  Pheidippides redux: reducing risk for acute cardiac events during marathon running.

Authors:  Arthur J Siegel
Journal:  Am J Med       Date:  2012-05-18       Impact factor: 4.965

5.  Sickle-cell trait as a risk factor for sudden death in physical training.

Authors:  J A Kark; D M Posey; H R Schumacher; C J Ruehle
Journal:  N Engl J Med       Date:  1987-09-24       Impact factor: 91.245

6.  Triggering of acute myocardial infarction by heavy physical exertion. Protection against triggering by regular exertion. Determinants of Myocardial Infarction Onset Study Investigators.

Authors:  M A Mittleman; M Maclure; G H Tofler; J B Sherwood; R J Goldberg; J E Muller
Journal:  N Engl J Med       Date:  1993-12-02       Impact factor: 91.245

7.  Running: the risk of coronary events : Prevalence and prognostic relevance of coronary atherosclerosis in marathon runners.

Authors:  Stefan Möhlenkamp; Nils Lehmann; Frank Breuckmann; Martina Bröcker-Preuss; Kai Nassenstein; Martin Halle; Thomas Budde; Klaus Mann; Jörg Barkhausen; Gerd Heusch; Karl-Heinz Jöckel; Raimund Erbel
Journal:  Eur Heart J       Date:  2008-04-21       Impact factor: 29.983

8.  Marathon cardiac deaths : the london experience.

Authors:  Dan S Tunstall Pedoe
Journal:  Sports Med       Date:  2007       Impact factor: 11.136

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.